Liege, Belgium – 11 December 2024 (07:30 CET) – Allegro NV, a biomedical companydeveloping transformative nanotechnology-based devices for degenerative joint disease, todayannounced […]
We are thrilled to announce that Allegro has won 3rd prize at the prestigious HealthTech Innovation Days (HTID) event in Paris! The […]
Read the interview with our CSO and co-founder Jorg Schelfhout in ‘De Tijd’. https://www.tijd.be/ondernemen/farma-biotech/jong-geweld-jorg-schelfhout-allegro-werken-in-een-vast-kader-sneed-me-de-adem-af/10557860.html
Allegro is honored to receive the esteemed China (Zhejiang) European Life Sciences Innovation Fund (ZELSIF) Award. This accolade, given to the most […]
We’ll be participating at the upcoming anniversary edition of “Knowledge 4 Growth” in Antwerp, upcoming May 15-16th. Knowledge for Growth is at […]
Last year, Allegro became part of the CPBT. The new Centre for Animal-Free Biomedical Translation (CPBT) aims to accelerate the transition to […]
The article discusses the rise of biotech companies in and around Liège, with a special focus on LégiaPark, a new hub for […]
At the prestigious BIO CEO & Investor Conference, Allegro and its CEO, Lucas Decuypere, seized the spotlight with an inspiring keynote address. […]
Allegro Biotech’s CEO, Lucas Decuypere, took center stage at the prestigious Discovery in Animal Health (DIAH) conference in Ghent, delivering a captivating […]
Allegro: Crowned Top 10 Biotech Company by LifeSciences Review In a resounding testament to its pioneering efforts in biomedical technologies, Allegro has […]